PG-102(MG12): Clinical Trials

1 trial of PG-102(MG12), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow PG-102(MG12): new trials by email Literature Review of PG-102(MG12) trials Research Report on PG-102(MG12)

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics and Pharmacodynamics Following Subcutaneous Injections of PG-102 (MG12) in Healthy Adult and Obesity Participants.
PG-102(MG12), Placebo - Healthy, Overweight
Phase 1CompletedProGen. Co., Ltd.1022024-03-042025-05-06

Conditions studied

Overweight (1)

Sponsors

ProGen. Co., Ltd. (1)

Countries

South Korea (1)

Top investigators

Seunghoon Han, MD (1)

Results publications

PMID 41876542